Diversity In Clinical Research: Improving Clinical Trial Representation With High-Quality Training

Over the last several years, the pharma industry, along with the world at large, has become increasingly focused on issues of diversity. This has been reflected in regulatory guidelines, government and industry policies and in the clinical trial recruitment phase of new drug research and development. However, relatively little attention has gone to diversity within the clinical research workforce, which many industry insiders have suggested can significantly enhance study population diversity.

But sponsors and research sites will need to invest in training to ensure that diversity and inclusiveness are priorities not only for individual clinical trials, but also for general operations.